Browsing by Author/Editor/Contributor Hobart, J.

Jump to a point in the index:
Showing results 1 to 6 of 6
Issue DateTitleAuthor(s)TypeCat.
2020One-Year Interim Analysis of Health-Related Quality of Life in RRMS Patients Treated With Alemtuzumab in a Real-world Clinical Setting (LemQoL Study)VAN WIJMEERSCH, Bart ; Harrower, T.; Hobart, J.; Kizlaitiene, R.; Marfia, G. A.; Patti, F.; Pearson, O. R.; Van Pesch, V.; Vanderdonckt, P.; Vecsei, L.; Shor, S.; Achiron, A.Journal ContributionM
2020Alemtuzumab Outcomes Over 9 Years in RRMS Patients With Highly Active Disease From CARE-MS I and II (TOPAZ)Ziemssen, T.; Bass, A. D.; Berkovich, R.; Eichau, S.; Hobart, J.; Hunter, S. F.; Limmroth, V.; Pelletier, D.; Pozzilli, C.; Schippling, S.; Singer, B. A.; Sousa, L.; Traboulsee, A.; Uittlehaag, B. M. J.; VAN WIJMEERSCH, Bart ; Poole, E. M.; Choudhry, Z.; Geertsen, S.; Daizadeh, N.; Comi, G.Journal ContributionM
2019Baseline characteristics of patients enrolled in LEMQoL, a study assessing health-related quality of life in RRMS patients treated with alemtuzumab in a real-world clinical settingVAN WIJMEERSCH, Bart ; Patti, F.; Hobart, J.; Kizlaitiene, R.; Vanderdonckt, P.; Shor, S.; Andreasen, A. K.; Uitdehaag, B. M.Journal ContributionM
2018Efficacy of prolonged-release fampridine vs placebo on walking ability, dynamic and static balance and quality-of-life: an integrated analysis of MOBILE and ENHANCEHupperts, R.; Hobart, J.; Gasperini, C.; Lycke, J.; Ziemssen, T.; FEYS, Peter ; McNeill, M.; Acosta, C.; Meergans, M.Journal ContributionM
2017Prolonged-release fampridine demonstrates rapid and sustained clinically meaningful improvements in walking ability over 24 weeks: MSWS-12 responders in the ENHANCE studyHobart, J.; Ziemssen, T.; FEYS, Peter ; Linnebank, M.; Goodman, A.; Farrell, R.; Hupperts, R.; Englishby, V.; McNeill, M.; Chang, I.; Lima, G.Journal ContributionM
2015Long-term efficacy and safety of prolonged-release fampridine treatment in patients with multiple sclerosis: design of the multicentre, randomised, double-blind, placebo-controlled ENHANCE studyZiemssen, T.; Hobart, J.; FEYS, Peter ; Linnebank, M.; Goodman, A.; McNeill, M.; Zhong, J.; Mehta, L.Journal ContributionM
Showing results 1 to 6 of 6